🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
2.420
-0.030 (-1.22%)
At close: Nov 20, 2026, 4:00 PM EST
2.415
-0.005 (-0.21%)
After-hours: Nov 20, 2026, 7:30 PM EST

Abeona Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1382862421245349
Market Cap Growth
-39.24%17.95%95.09%134.61%7.07%-68.06%
Enterprise Value
201031567643-11
Last Close Price
2.425.275.575.013.088.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-4.01----
Forward PE
-231.80----
PS Ratio
3.5549.07-35.4637.4116.47
PB Ratio
1.101.795.508.371.981.17
P/TBV Ratio
1.101.795.508.371.981.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.5117.63-21.7330.43-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.130.160.520.360.280.22
Net Debt / Equity Ratio
-0.94-1.04-1.70-3.16-1.66-0.84
Net Debt / EBITDA Ratio
1.701.921.201.021.060.66
Net Debt / FCF Ratio
1.781.971.281.251.020.51
Asset Turnover
0.190.04-0.060.020.03
Quick Ratio
5.466.705.994.076.732.89
Current Ratio
5.696.936.084.156.833.39
Return on Equity (ROE)
-42.09%70.05%-216.57%-260.60%-114.85%-117.22%
Return on Assets (ROA)
-31.03%43.34%-73.71%-84.53%-60.47%-73.61%
Return on Invested Capital (ROIC)
-67.07%-63.27%-89.85%-90.08%-143.32%-499.52%
Return on Capital Employed (ROCE)
-50.30%-47.10%-69.50%-95.30%-80.20%-91.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.51%24.93%-26.32%-43.66%-75.04%-171.90%
FCF Yield
-47.97%-29.52%-24.14%-30.09%-82.44%-141.30%
Buyback Yield / Dilution
7.83%-61.12%-91.99%-171.96%-99.65%-6.24%
SEC Filings: 10-K · 10-Q